封面
市场调查报告书
商品编码
1386278

即时照护 (POCT) 市场报告:2030 年趋势、预测与竞争分析

Point-of-Care (POCT) Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

即时照护 (POCT) 趋势与预测

到 2030 年,全球定点医疗 (POCT) 市场预计将达到 700 亿美元,2024 年至 2030 年年复合成长率为 10.3%。该市场的主要驱动力是对疾病早期诊断和治疗的需求不断增长、远端医疗和远距医疗保健服务的日益采用以及对负担得起且易于使用的即时检测设备的需求不断增长。全球即时照护 (POCT) 市场的未来前景广阔,医院、诊断中心、实验室和居家医疗环境市场都充满机会。

护理点 (POCT) 市场洞察

Lucintel 预测,由于血糖值测试的便利性、易用性以及在家中或医疗保健环境中进行的能力,血糖测试将在预测期内实现最高增长。

预计北美地区在预测期内将出现最高的成长。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和业务风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球即时照护 (POCT) 市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球即时照护 (POCT) 市场趋势(2018-2023)和预测(2024-2030)
  • 按产品类型分類的全球护理点 (POCT) 市场
    • 血糖监测
    • 仪表
    • 柳叶刀
    • 心臟代谢测试
    • 心臟标记测试
    • 其他的
  • 按技术分類的全球护理点 (POCT) 市场
    • 侧流层析
    • 量油尺
    • 微流体学
    • 分子诊断
    • 免疫学测试
    • 凝集试验
    • 流经
    • 固相
    • 生物感测器
  • 按应用分類的全球护理点 (POCT) 市场
    • 心臟代谢测试
    • 传染病检查
    • 肾臟病学测试
    • 药物滥用测试
    • 血糖测试
    • 怀孕测试
    • 癌症生物标记测试
    • 其他的
  • 按最终用途分類的全球护理点 (POCT) 市场
    • 医院
    • 诊断中心
    • 调查
    • 家庭护理设置
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球护理点 (POCT) 市场
  • 北美即时护理 (POCT) 市场
  • 欧洲即时护理 (POCT) 市场
  • 亚太地区护理点 (POCT) 市场
  • 其他地区的即时护理(POCT)市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球护理点 (POCT) 市场成长机会
    • 全球即时护理 (POCT) 市场成长机会(按技术)
    • 全球护理点 (POCT) 市场成长机会(按应用)
    • 按最终用途分類的全球护理点 (POCT) 市场成长机会
    • 按地区分類的全球护理点 (POCT) 市场成长机会
  • 全球即时护理 (POCT) 市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球即时护理 (POCT) 市场的产能
    • 全球即时护理 (POCT) 市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Abbott
  • F. Hoffmann-La Roche
  • BD
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • Danaher
  • Sekisui Diagnostics
简介目录

Point-of-Care (POCT) Trends and Forecast

The future of the global point-of-care (POCT) market looks promising with opportunities in the hospital, diagnostic center, research laboratory, and home-care setting markets. The global point-of-care (POCT) market is expected to reach an estimated $70.0 billion by 2030 with a CAGR of 10.3% from 2024 to 2030. The major drivers for this market are augmenting demand for early diagnosis and treatment of diseases, expanding adoption of telehealth and remote healthcare delivery, and growing demand for affordable and user-friendly point of care testing devices.

A more than 150-page report is developed to help in your business decisions.

Point-of-Care (POCT) by Segment

The study includes a forecast for the global point-of-care (POCT) by product type, technology, application, end use, and region.

Point-of-Care (POCT) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Glucose Monitoring
  • Strips
  • Meters
  • Lancets
  • Cardiometabolic Testing
  • Cardiac Marker Testing
  • Others

Point-of-Care (POCT) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays
  • Agglutination Assays
  • Flow-Through
  • Solid Phase
  • Biosensors

Point-of-Care (POCT) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardio Metabolic Testing
  • Infectious Disease Testing
  • Nephrology Testing
  • Drug-of-Abuse Testing
  • Blood Glucose Testing
  • Pregnancy Testing
  • Cancer Biomarker Testing
  • Others

Point-of-Care (POCT) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Home-Care Settings
  • Others

Point-of-Care (POCT) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Point-of-Care (POCT) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies point-of-care (POCT) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the point-of-care (POCT) companies profiled in this report include-

  • Abbott
  • F. Hoffmann-La Roche
  • B.D.
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • Danaher
  • Sekisui Diagnostics

Point-of-Care (POCT) Market Insights

Lucintel forecasts that blood glucose testing is expected to witness highest growth over the forecast period due to its features, such as convenience, easy to use, and can be performed at home or in a healthcare setting.

North America is expected to witness highest growth over the forecast period.

Features of the Global Point-of-Care (POCT) Market

Market Size Estimates: Point-of-care (POCT) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Point-of-care (POCT) market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Point-of-care (POCT) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the point-of-care (POCT) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the point-of-care (POCT) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the point-of-care (POCT) market size?

Answer: The global point-of-care (POCT) market is expected to reach an estimated $70.0 billion by 2030.

Q.2 What is the growth forecast for point-of-care (POCT) market?

Answer: The global point-of-care (POCT) market is expected to grow with a CAGR of 10.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the point-of-care (POCT) market?

Answer: The major drivers for this market are augmenting demand for early diagnosis and treatment of diseases, expanding adoption of telehealth and remote healthcare delivery, and growing demand for affordable and user-friendly point of care testing devices.

Q4. What are the major segments for point-of-care (POCT) market?

Answer: The future of the point-of-care (POCT) market looks promising with opportunities in the hospital, diagnostic center, research laboratory, and home-care setting markets.

Q5. Who are the key point-of-care (POCT) market companies?

Answer: Some of the key point-of-care (POCT) companies are as follows:

  • Abbott
  • F. Hoffmann-La Roche
  • B.D.
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • Danaher
  • Sekisui Diagnostics

Q6. Which point-of-care (POCT) market segment will be the largest in future?

Answer: Lucintel forecasts that blood glucose testing is expected to witness highest growth over the forecast period due to its features, such as convenience, easy to use, and can be performed at home or in a healthcare setting.

Q7. In point-of-care (POCT) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the point-of-care (POCT) market by product type (glucose monitoring, strips, meters, lancets, cardiometabolic testing, cardiac marker testing, and others), technology (lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, agglutination assays, flow-through, solid phase, and biosensors), application (cardio metabolic testing, infectious disease testing, nephrology testing, drug-of-abuse testing, blood glucose testing, pregnancy testing, cancer biomarker testing, and others), end use (hospitals, diagnostic centers, research laboratories, home-care settings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Point-of-Care (POCT) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Point-of-Care (POCT) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Point-of-Care (POCT) Market by Product Type
    • 3.3.1: Glucose Monitoring
    • 3.3.2: Strips
    • 3.3.3: Meters
    • 3.3.4: Lancets
    • 3.3.5: Cardiometabolic Testing
    • 3.3.6: Cardiac marker Testing
    • 3.3.7: Others
  • 3.4: Global Point-of-Care (POCT) Market by Technology
    • 3.4.1: Lateral Flow Assays
    • 3.4.2: Dipsticks
    • 3.4.3: Microfluidics
    • 3.4.4: Molecular Diagnostics
    • 3.4.5: Immunoassays
    • 3.4.6: Agglutination Assays
    • 3.4.7: Flow-Through
    • 3.4.8: Solid Phase
    • 3.4.9: Biosensors
  • 3.5: Global Point-of-Care (POCT) Market by Application
    • 3.5.1: Cardio Metabolic Testing
    • 3.5.2: Infectious Disease Testing
    • 3.5.3: Nephrology Testing
    • 3.5.4: Drug-of-Abuse Testing
    • 3.5.5: Blood Glucose Testing
    • 3.5.6: Pregnancy Testing
    • 3.5.7: Cancer Biomarker Testing
    • 3.5.8: Others
  • 3.6: Global Point-of-Care (POCT) Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Diagnostic Centers
    • 3.6.3: Research Laboratories
    • 3.6.4: Home-Care Settings
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Point-of-Care (POCT) Market by Region
  • 4.2: North American Point-of-Care (POCT) Market
    • 4.2.1: North American Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.2.2: North American Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others
  • 4.3: European Point-of-Care (POCT) Market
    • 4.3.1: European Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.3.2: European Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others
  • 4.4: APAC Point-of-Care (POCT) Market
    • 4.4.1: APAC Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.4.2: APAC Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others
  • 4.5: ROW Point-of-Care (POCT) Market
    • 4.5.1: ROW Point-of-Care (POCT) Market by Application: Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing, and Others
    • 4.5.2: ROW Point-of-Care (POCT) Market by End Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Point-of-Care (POCT) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Point-of-Care (POCT) Market by Technology
    • 6.1.3: Growth Opportunities for the Global Point-of-Care (POCT) Market by Application
    • 6.1.4: Growth Opportunities for the Global Point-of-Care (POCT) Market by End Use
    • 6.1.5: Growth Opportunities for the Global Point-of-Care (POCT) Market by Region
  • 6.2: Emerging Trends in the Global Point-of-Care (POCT) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Point-of-Care (POCT) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Point-of-Care (POCT) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: F. Hoffmann-La Roche
  • 7.3: B.D.
  • 7.4: Siemens Healthcare
  • 7.5: Bio-Rad Laboratories
  • 7.6: Danaher
  • 7.7: Sekisui Diagnostics